Literature DB >> 8626992

A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium.

J Merayo-Lloves1, T Z Zhao, J E Dutt, C S Foster.   

Abstract

BACKGROUND: Allergic conjunctivitis is the most common atopic disease affecting the eye. To study the pathophysiology and effectiveness of antiallergic drugs, it is necessary to develop animal models that closely mimic human allergic conjunctivitis.
OBJECTIVE: The study was performed to develop an experimental murine model of ocular allergic conjunctivitis to an airborne allergen.
METHODS: SWR/J mice were divided into the following groups: group 1, untreated, experimental; group 2, phosphate-buffered saline-treated; group 3, nedocromil sodium-treated; and group 4, unmanipulated controls. Groups 1, 2, and 3 were exposed to ragweed by topical contact with the nasal and conjunctival mucosae. Allergic conjunctivitis was evaluated by scoring of clinical signs, serum IgE levels, and histologic findings.
RESULTS: Mice exposed to ragweed had clinicopathologic signs of allergic conjunctivitis and specific anti-ragweed IgE. Allergic conjunctivitis was modulated by nedocromil sodium. Treated mice had fewer clinical signs of allergy, lower levels of ragweed-specific IgE, reduction of conjunctival eosinophil infiltration, decrease in the number of intact and degranulating mast cells, and reduction of cytokine release.
CONCLUSION: This is the first report of a murine model of allergic conjunctivitis to an airborne allergen that can be used to study the disease pathophysiology and its response to treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626992     DOI: 10.1016/s0091-6749(96)70268-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

Review 1.  Ocular allergy treatments.

Authors:  L Bielory
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model.

Authors:  Ying Chen; Xianfei Hong
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

Review 3.  Animal models of ocular allergy and their clinical correlations.

Authors:  Margarita Calonge; Karyn F Siemasko; Michael E Stern
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

Review 4.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

5.  Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis.

Authors:  Jiayu Bao; Lei Tian; Yifan Meng; Binge Wu; Jingyi Wang; Jing He; Qiyan Shao; Chengshuo Wang; Ying Jie; Luo Zhang
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

6.  Conditioned Medium of Human Amniotic Epithelial Cells Alleviates Experimental Allergic Conjunctivitis Mainly by IL-1ra and IL-10.

Authors:  Binxin Wu; Furong Gao; Jianhua Lin; Lixia Lu; Huiming Xu; Guo-Tong Xu
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

7.  Azithromycin reduces inflammation in a rat model of acute conjunctivitis.

Authors:  Patricia Fernandez-Robredo; Sergio Recalde; Maite Moreno-Orduña; Laura García-García; Javier Zarranz-Ventura; Alfredo García-Layana
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.